We found that CSO treatment significantly inhibited the hyperactivation of microglia and astrocytes and significantly decreased the expression levels of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) in the ischemia penumbra after MCAO-R injury. The gene discussed is IL1B; the disease is craniosynostosis.